When is AITRICS VitalCare the better choice?

It publishes the first subgroup performance reporting located for any vendor in this category, and names its architecture rather than calling it proprietary. The general ward is the stated focus, which is the harder detection problem because ward patients are observed intermittently. Development and external validation are published under full conflict disclosure, which is rare in this lane.

When is CLEW Medical the better choice?

It publishes the operating characteristics of its cleared models in a public regulatory document, so sensitivity and specificity are readable rather than asserted. The cleared indications carry an explicit adjunctive constraint, which bounds what a hospital may build on top of them. It produced the first direct measurement of this category's defining failure, comparing model output against what clinicians actually did.

AITRICS VitalCare vs CLEW Medical

Last VerifiedAugust 4, 2026

Verdict

The two most transparent vendors in inpatient deterioration, publishing different halves of what a buyer needs. AITRICS published the first subgroup performance reporting located in this category, names its architecture plainly and targets the general ward, where patients are observed intermittently and deterioration is most often missed. CLEW publishes the operating characteristics of its cleared models in a public regulatory document and produced the first study comparing model output against what clinicians actually did, which is this category's defining failure and one nobody else has measured. Between them they define the disclosure standard for the lane. Ask each for what the other publishes, and both for alerts per patient day, because a model nobody can act on at volume is not deployable regardless of its numbers.

Select AITRICS VitalCare if

It publishes the first subgroup performance reporting located for any vendor in this category, and names its architecture rather than calling it proprietary.
The general ward is the stated focus, which is the harder detection problem because ward patients are observed intermittently.
Development and external validation are published under full conflict disclosure, which is rare in this lane.

Select CLEW Medical if

It publishes the operating characteristics of its cleared models in a public regulatory document, so sensitivity and specificity are readable rather than asserted.
The cleared indications carry an explicit adjunctive constraint, which bounds what a hospital may build on top of them.
It produced the first direct measurement of this category's defining failure, comparing model output against what clinicians actually did.

Attribute Matrix

Side by Side

Axis	A AITRICS VitalCare	C CLEW Medical
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Inpatient Deterioration & Risk Monitoring page.

AITRICS VitalCare vs Bayesian Health→AITRICS VitalCare vs Epic Sepsis Model→AITRICS VitalCare vs Healthplus.ai→CLEW Medical vs Etiometry→CLEW Medical vs Luminare→

Disclosure

These are the two most transparent records in deterioration and they are transparent about different things, one about fairness and architecture and the other about operating characteristics and clinician response, so a buyer should ask each for what the other publishes. Regulatory scopes are not equivalent: AITRICS holds a United States clearance that does not cover the product marketed elsewhere, and CLEW's models are explicitly adjunctive. Neither publishes an alert burden per patient day, which determines whether either survives a working ward.